Article
Expression of excision repair cross-complementation group 1 and class III beta-tubulin predict survival after chemotherapy for completely resected non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) - 1 Oct 2008
Okuda Katsuhiro, Sasaki Hidefumi, Dumontet Charles, Kawano Osamu, Yukiue Haruhiro, Yokoyama Tomoki, Yano Motoki, Fujii Yoshitaka
Abstract excerpt
In this study, we examined the expression of excision repair cross-complementation group 1 (ERCC1) protein in 90 completely resected lung cancer samples from patients who received adjuvant or neo-adjuvant platinum-based chemotherapy. Epidermal growth factor receptor (EGFR) was also studied in these samples. We also examined class III beta-tubulin protein expression in 50 patients treated with a platinum-based...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.